Richard William Scalzo Glycomimetics Inc (GLYC) insider trading activity

Richard William Scalzo is Chief Financial Officer of GLYCOMIMETICS INC. Currently has a direct ownership of 19,422 shares of GLYC, which is worth approximately $304,925. The most recent transaction as insider was on Dec 15, 2025, when has been sold 19,422 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.4K

n/a 3M change

n/a 12M change

Total Value Held $304,925

Richard William Scalzo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 15 2025	BUY Grant, award, or other acquisition	-	19,422 Added 50.0%	19,422 Ordinary Shares

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

SVP, Head of Finance & Admin.

RWS